Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment: Clinical and Translational Oncology

A. Bonaventura, F. Grossi, F. Carbone, A. Vecchié, S. Minetti, N. Bardi, E. Elia, A.M. Ansaldo, D. Ferrara, E. Rijavec, M.G. Dal Bello, G. Rossi, F. Biello, M. Tagliamento, A. Alama, S. Coco, P. Spallarossa, F. Dallegri, C. Genova, F. Montecucco

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment: Clinical and Translational Oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences